Establishing Safe Drainage Limits for Pleural Chest Tube Removal.
NCT ID: NCT00574002
Last Updated: 2017-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2007-12-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Drainage Amount for Removal of Thoracostomy Tube
NCT00575198
Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes
NCT01551082
Safety of Early Removal of Chest Tubes After Thoracoscopic Lung Biopsies
NCT02727218
Chest Tube Drainage of Transudative Pleural Effusions Hastens Liberation From Mechanical Ventilation
NCT01104285
Evaluation of Fluid Output Threshold for Safe Chest Tube Removal - A Potential Way to Decrease Length of Stay in Hospital and to Improve Postoperative Care After Lung Surgery?
NCT03093610
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Patients that have their chest tube removed when drainage is 400mL or less in 24 hours.
No interventions assigned to this group
Group B.
Patients that have their chest tube removed when drainage is 200mL or less in 24 hours.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No air leak present
* Fluid is not infected
* Pleural drainage of fluid was an indication for placement of the chest tube
* Patient is post-thoracic surgery
* Patient is post-thoracic trauma
* Informed consent obtained
Exclusion Criteria
* Infected pleural fluid
* Active intra-thoracic bleeding
* Thoracic empyema
* Non-removal of chest tube (i.e.: expired)
* Pregnancy
* Less than 18 years of age
* Unable to obtain informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Missouri, Kansas City
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerald L. Early, M.D., M.A.
Role: PRINCIPAL_INVESTIGATOR
Truman Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Truman Medical Center
Kansas City, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-68e
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.